Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions.
Publication
, Journal Article
Mannelli, P
Published in: Addiction
November 2024
Duke Scholars
Published In
Addiction
DOI
EISSN
1360-0443
Publication Date
November 2024
Volume
119
Issue
11
Start / End Page
1973 / 1974
Location
England
Related Subject Headings
- Substance Abuse
- Secondary Prevention
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Narcotic Antagonists
- Humans
- Delivery of Health Care, Integrated
- Buprenorphine
- 5203 Clinical and health psychology
- 4206 Public health
Citation
APA
Chicago
ICMJE
MLA
NLM
Mannelli, P. (2024). Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions. Addiction, 119(11), 1973–1974. https://doi.org/10.1111/add.16672
Mannelli, Paolo. “Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions.” Addiction 119, no. 11 (November 2024): 1973–74. https://doi.org/10.1111/add.16672.
Mannelli P. Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions. Addiction. 2024 Nov;119(11):1973–4.
Mannelli, Paolo. “Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions.” Addiction, vol. 119, no. 11, Nov. 2024, pp. 1973–74. Pubmed, doi:10.1111/add.16672.
Mannelli P. Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions. Addiction. 2024 Nov;119(11):1973–1974.
Published In
Addiction
DOI
EISSN
1360-0443
Publication Date
November 2024
Volume
119
Issue
11
Start / End Page
1973 / 1974
Location
England
Related Subject Headings
- Substance Abuse
- Secondary Prevention
- Opioid-Related Disorders
- Opiate Substitution Treatment
- Narcotic Antagonists
- Humans
- Delivery of Health Care, Integrated
- Buprenorphine
- 5203 Clinical and health psychology
- 4206 Public health